Patients with severe COVID-19 develop antibodies faster than those with a mild case of the disease. A team of researchers from Tel Aviv University and the Sharon Hospital at the Rabin Medical Center, led by Prof. Motti Gerlic and Prof. Arie [...]

Research finds approximately 70% of the infections in Israel were caused by a SARS-CoV2 strain imported from the United States A  team of Tel Aviv University researchers led by Dr. Adi Stern of the School of Molecular Cell Biology and Biote [...]

The epitope-based vaccine will target the most vulnerable part of the viral spike protein Ramot, Tel Aviv University’s technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Gr [...]

The Center will bring together experts in the field and help the State of Israel deal epidemic-related crises Tel Aviv University has announced the establishment of the Center for Combating Pandemics, a first of its kind multidisciplinary e [...]